Zai Lab (ZLAB) News Today $31.18 +0.03 (+0.10%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$31.16 -0.02 (-0.06%) As of 06:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Envestnet Asset Management Inc. Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB)Envestnet Asset Management Inc. bought a new position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 37,278 shares of the company's stock, valued at approximaMay 4 at 3:14 AM | marketbeat.comRA Capital Management L.P. Buys Shares of 1,295,040 Zai Lab Limited (NASDAQ:ZLAB)RA Capital Management L.P. purchased a new stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 1,295,040 shares of the company's stock, valuedMay 3 at 7:49 AM | marketbeat.comZai Lab (ZLAB) to Release Quarterly Earnings on ThursdayZai Lab (NASDAQ:ZLAB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-zai-lab-limited-stock/)May 3 at 6:39 AM | marketbeat.comGeode Capital Management LLC Boosts Position in Zai Lab Limited (NASDAQ:ZLAB)Geode Capital Management LLC boosted its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 27.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 55,520 shares of the company's stock after buying an additional 11,894 shares during the period. GeoMay 3 at 3:20 AM | marketbeat.comWells Fargo & Company MN Grows Stake in Zai Lab Limited (NASDAQ:ZLAB)Wells Fargo & Company MN raised its stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 8,090.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 40,954 shares of the company's stock after acquiring an addMay 2 at 3:25 AM | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - Here's What HappenedZai Lab (NASDAQ:ZLAB) Shares Gap Down - Should You Sell?May 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Raises Position in Zai Lab Limited (NASDAQ:ZLAB)Price T Rowe Associates Inc. MD boosted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 30.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,354,025 shares of the company's stock after bMay 1, 2025 | marketbeat.comLegal & General Group Plc Reduces Holdings in Zai Lab Limited (NASDAQ:ZLAB)Legal & General Group Plc lowered its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 19.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 82,727 shares of the company's stock after selling 19,623 shares during the period. LApril 27, 2025 | marketbeat.comZai Lab presents data from studies evaluating two oncology therapiesApril 26, 2025 | markets.businessinsider.comXTX Topco Ltd Has $353,000 Position in Zai Lab Limited (NASDAQ:ZLAB)XTX Topco Ltd lowered its stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 57.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,487 shares of the company's stock after selling 18,131 shares during theApril 26, 2025 | marketbeat.comZai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025April 25, 2025 | businesswire.comMarshall Wace LLP Acquires Shares of 288,992 Zai Lab Limited (NASDAQ:ZLAB)Marshall Wace LLP bought a new position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 288,992 shares of the company's stock, valued at approApril 25, 2025 | marketbeat.comTownsquare Capital LLC Invests $243,000 in Zai Lab Limited (NASDAQ:ZLAB)Townsquare Capital LLC acquired a new stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 9,290 shares of the company's stock, valued at approximately $243,000. A number ofApril 25, 2025 | marketbeat.comCantor Fitzgerald Reduces Earnings Estimates for Zai LabApril 25, 2025 | americanbankingnews.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - Still a Buy?Zai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next?April 24, 2025 | marketbeat.comEversept Partners LP Has $2.70 Million Stock Position in Zai Lab Limited (NASDAQ:ZLAB)Eversept Partners LP cut its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 23.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 102,930 shares of the company's stock after seApril 24, 2025 | marketbeat.comZai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual MeetingApril 23, 2025 | finance.yahoo.comRock Springs Capital Management LP Decreases Stock Position in Zai Lab Limited (NASDAQ:ZLAB)Rock Springs Capital Management LP reduced its position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 0.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,305,337 shares of the company's stock after selling 10,336 shares during the quarter. ZaApril 23, 2025 | marketbeat.comB Group Inc. Acquires New Shares in Zai Lab Limited (NASDAQ:ZLAB)B Group Inc. bought a new stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 400,000 shares of the company's stock, valued at approximatelyApril 23, 2025 | marketbeat.comCapital International Investors Purchases 120,000 Shares of Zai Lab Limited (NASDAQ:ZLAB)Capital International Investors raised its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 82.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 264,986 shares of the company's stock after buying an additionalApril 23, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Position Boosted by Renaissance Technologies LLCRenaissance Technologies LLC boosted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 112.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 187,800 shares of the company's stock aftApril 22, 2025 | marketbeat.comZai Lab announces China NMPA acceptance of repotrectinib sNDAApril 21, 2025 | markets.businessinsider.comZai Lab Flat as China Okays ApplicationApril 21, 2025 | baystreet.caScotiabank Keeps Their Buy Rating on Zai Lab (ZLAB)April 21, 2025 | markets.businessinsider.comZai Lab gets China's acceptance for label expansion of repotrectinibApril 21, 2025 | msn.comZai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid TumorsApril 21, 2025 | businesswire.comJPMorgan Chase & Co. Buys 23,510 Shares of Zai Lab Limited (NASDAQ:ZLAB)JPMorgan Chase & Co. increased its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 17.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 161,635 shares of the company's stocApril 21, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Trading Down 6.1% - Here's What HappenedZai Lab (NASDAQ:ZLAB) Shares Down 6.1% - What's Next?April 18, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - What's Next?Zai Lab (NASDAQ:ZLAB) Shares Gap Down - What's Next?April 17, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Sees Large Volume Increase - Should You Buy?Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume - Still a Buy?April 16, 2025 | marketbeat.comAll You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to BuyApril 15, 2025 | msn.comFIL Ltd Decreases Stock Position in Zai Lab Limited (NASDAQ:ZLAB)FIL Ltd trimmed its position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 11.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 111,713 shares of the company's stock after selling 14,228 shares during the quartApril 15, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Shares Purchased by Fmr LLCFmr LLC raised its position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 749.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,475,505 shares of the company's stock after purchasing an additional 4,830,646 shares during the period. Fmr LLC ownedApril 15, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 25,938 Shares of Zai Lab Limited (NASDAQ:ZLAB)Russell Investments Group Ltd. lessened its position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 231,694 shares of the company's stock after selling 25,938 shares duApril 15, 2025 | marketbeat.comDymon Asia Capital Singapore PTE. LTD. Makes New $524,000 Investment in Zai Lab Limited (NASDAQ:ZLAB)Dymon Asia Capital Singapore PTE. LTD. purchased a new position in Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 20,000 shares of the company's stock, valued at aApril 13, 2025 | marketbeat.comOrion Portfolio Solutions LLC Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB)Orion Portfolio Solutions LLC purchased a new position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,956 shares of the company's stoApril 12, 2025 | marketbeat.comZai Lab (NASDAQ:ZLAB) Shares Down 7.1% on Insider SellingZai Lab (NASDAQ:ZLAB) Shares Down 7.1% After Insider SellingApril 11, 2025 | marketbeat.comZai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff RolloutApril 10, 2025 | msn.comADAR1 Capital Management LLC Has $27.39 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB)ADAR1 Capital Management LLC boosted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 96.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,045,837 shares of the company's stock after acquiring an additional 513,383 shares durApril 9, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CFO Yajing Chen Sells 924 SharesApril 9, 2025 | insidertrades.comYajing Chen Sells 924 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 924 shares of the company's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $33.11, for a total value of $30,593.64. Following the transaction, the chief financial officer now directly owns 27,047 shares of the company's stock, valued at approximately $895,526.17. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link.April 9, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Insider Frazor Titus Edmondson III Sells 1,874 SharesZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 1,874 shares of the stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $33.11, for a total transaction of $62,048.14. Following the completion of the transaction, the insider now directly owns 30,375 shares of the company's stock, valued at $1,005,716.25. This trade represents a 5.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.April 9, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CEO Sells $97,508.95 in StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 2,945 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $33.11, for a total transaction of $97,508.95. Following the sale, the chief executive officer now owns 479,851 shares of the company's stock, valued at $15,887,866.61. This trade represents a 0.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.April 9, 2025 | marketbeat.comZai Lab management to meet with Cantor FitzgeraldApril 8, 2025 | markets.businessinsider.comZai Lab (ZLAB) Gets a Buy from ScotiabankApril 8, 2025 | markets.businessinsider.comSchroder Investment Management Group Decreases Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB)Schroder Investment Management Group cut its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 61.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 91,504 shares of the company's stocApril 8, 2025 | marketbeat.comFrazor Titus Edmondson III Sells 4,369 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 4,369 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $35.89, for a total value of $156,803.41. Following the completion of the sale, the insider now owns 27,217 shares of the company's stock, valued at $976,818.13. This trade represents a 13.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.April 5, 2025 | marketbeat.comYajing Chen Sells 5,280 Shares of Zai Lab Limited (NASDAQ:ZLAB) StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 5,280 shares of Zai Lab stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $35.89, for a total value of $189,499.20. Following the completion of the transaction, the chief financial officer now owns 25,471 shares of the company's stock, valued at $914,154.19. This trade represents a 17.17 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.April 5, 2025 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) CEO Sells $208,449.12 in StockZai Lab Limited (NASDAQ:ZLAB - Get Free Report) CEO Ying Du sold 5,808 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $35.89, for a total value of $208,449.12. Following the completion of the transaction, the chief executive officer now owns 476,046 shares in the company, valued at $17,085,290.94. The trade was a 1.21 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.April 5, 2025 | marketbeat.comRaymond James Financial Inc. Purchases Shares of 39,420 Zai Lab Limited (NASDAQ:ZLAB)Raymond James Financial Inc. purchased a new stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 39,420 shares of the company's stock, valued atApril 5, 2025 | marketbeat.com Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address ZLAB Media Mentions By Week ZLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼1.370.73▲Average Medical News Sentiment ZLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼75▲ZLAB Articles Average Week Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intra-Cellular Therapies News Genmab A/S News Dr. Reddy's Laboratories News Moderna News Ascendis Pharma A/S News Viatris News Qiagen News Roivant Sciences News Revolution Medicines News Lantheus News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZLAB Stock Free ZLAB Stock Alerts